xestoquinone has been researched along with Malaria in 1 studies
*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ausseil, F; Chevalley, S; Debitus, C; Desoubzdanne, D; Doerig, C; Dorin, D; Marcourt, L; Raux, R; Valentin, A | 1 |
1 other study(ies) available for xestoquinone and Malaria
| Article | Year |
|---|---|
Alisiaquinones and alisiaquinol, dual inhibitors of Plasmodium falciparum enzyme targets from a New Caledonian deep water sponge.
Topics: Alkyl and Aryl Transferases; Animals; Antimalarials; Cell Cycle Proteins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Malaria; Marine Biology; Molecular Structure; New Caledonia; NIMA-Related Kinase 1; Plasmodium falciparum; Porifera; Protein Serine-Threonine Kinases; Terpenes | 2008 |